AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2012
Mar 9, 2012
31523_dirs_2012-03-09_9942e0e8-4e67-46a0-98c7-7b83b73736c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-03-07
Reporting Person: BARRETT M JAMES (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-07 | Common Stock | P | 925154 | $5.70 | Acquired | 4584311 | Indirect |
Footnotes
F1: On March 7, 2012, New Enterprise Associates 11, Limited Partnership ("NEA 11"), purchased 925,154 shares of Common Stock in the Issuer's registered underwritten public offering at the price to the public of $5.70 per share.
F2: The Reporting Person is an individual manager of NEA 11 GP, LLC, the sole general partner of NEA Partners 11, Limited Partnership ("NEA Partners 11"). NEA Partners 11 is the sole general partner of NEA 11, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 11 securities in which the Reporting Person has no pecuniary interest.